On June 10, 2025, Bausch + Lomb, a subsidiary of Bausch Health Companies Inc., announced a €600 million offer of senior secured floating rate notes and plans for a $2.2 billion new term B loan facility and an $800 million revolving credit facility to refinance existing debt and support corporate purposes.